Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).
Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.
Ayusawa
Mamoru
M
Department of Pediatrics, Nihon University School of Medicine, Tokyo 173-8610, Japan. maysw@med.nihon-u.ac.jp
Sonobe
Tomoyoshi
T
Uemura
Shigeru
S
Ogawa
Shunnichi
S
Nakamura
Yoshikazu
Y
Kiyosawa
Nobuyuki
N
Ishii
Masahiro
M
Harada
Kensuke
K
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000188:drug therapy
D016756:Immunoglobulins, Intravenous